4

Making the difference

Helping women, children and their families
make informed and powerful decisions about
their health

3

Global collaboration

Bringing together experts from all over the world
to improve maternal and child health

2

Understanding the Immune Response

Harnessing the body’s response to HIV and antiretrovirals
to improve treatment and quality of life

2

Fighting Antimicrobial Resistance

Ensuring effective treatments are available for common infections
for generations to come

1

The right drug, the right dose

Generating scientific information necessary to market drugs
at doses that are safe and effective for children

6

Working smarter, not harder

Standardizing best practices across disease areas
and populations to improve paediatric infectious disease research

5

SCIENTIFIC RESEARCH

Paving the way to better healthcare
and better lives.

LATEST NEWS

2nd International Meeting on Childhood Tuberculosis

25 October, 2017 - 2:55:57

The 2nd International Meeting on Childhood Tubercolosis will take place in Vilnius, Lithuania on March 21st-23rd, 2018. The flyer is now available for download. The program and information about the venue and logistics will be available soon. For pre- registration, please email c.male@ucl.ac.uk  READ MORE

THE PENTA ID NETWORK

The PENTA-ID Network brings together key stakeholders in paediatric infectious disease, including researchers, clinicians, regulatory bodies, the pharmaceutical industry and patients and their families, to plan and carry out high quality clinical research and training. The network began in 1991 as PENTA, the Paediatric European Network for Treatment of AIDS, and focused on conducting clinical trials on antiretroviral therapy among HIV-infected children. It later integrated with the European Collaborative Study, one of the largest cohorts of children born to HIV-positive mothers.

In 2011 the network officially became PENTA-ID (Infectious Diseases), expanding and applying its expertise in HIV to other paediatric infectious diseases. The network now spans over 90 clinical sites in 18 countries, providing the access to paediatric patients necessary to perform clinical research, and leverages the expertise and experience in paediatric infectious disease of hundreds of participating researchers and physicians. In addition to coordinating and participating in trials and cohort studies, the network develops treatment guidelines and training programmes for health care professionals on various aspects of prevention and treatment of paediatric infectious disease, and contributes to European and global efforts to improve research infrastructure and harmonize and streamline research methods.

ALWAYS EXPANDING

The PENTA-ID network continues to grow, bringing together patients and their care-givers worldwide to address a wide range of healthcare issues.

90

CLINICAL SITES

18

COUNTRIES

25

YEARS OF ACTIVITY

19

PROJECTS COORDINATED